000 | 01850 a2200541 4500 | ||
---|---|---|---|
005 | 20250516054018.0 | ||
264 | 0 | _c20120516 | |
008 | 201205s 0 0 eng d | ||
022 | _a1937-335X | ||
024 | 7 |
_a10.1089/ten.TEA.2011.0234 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aScotti, Celeste | |
245 | 0 | 0 |
_aResponse of human engineered cartilage based on articular or nasal chondrocytes to interleukin-1β and low oxygen. _h[electronic resource] |
260 |
_bTissue engineering. Part A _cFeb 2012 |
||
300 |
_a362-72 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aCartilage Oligomeric Matrix Protein |
650 | 0 | 4 |
_aCartilage, Articular _xcytology |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aChondrocytes _xcytology |
650 | 0 | 4 |
_aCollagen Type II _xmetabolism |
650 | 0 | 4 |
_aEpitopes _xmetabolism |
650 | 0 | 4 |
_aExtracellular Matrix Proteins _xmetabolism |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlycoproteins _xmetabolism |
650 | 0 | 4 |
_aGlycosaminoglycans _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterleukin-1beta _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMatrilin Proteins |
650 | 0 | 4 |
_aMatrix Metalloproteinases _xmetabolism |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNose _xcytology |
650 | 0 | 4 |
_aOxygen _xpharmacology |
650 | 0 | 4 |
_aTissue Engineering _xmethods |
650 | 0 | 4 |
_aTissue Scaffolds _xchemistry |
700 | 1 | _aOsmokrovic, Andrea | |
700 | 1 | _aWolf, Francine | |
700 | 1 | _aMiot, Sylvie | |
700 | 1 | _aPeretti, Giuseppe M | |
700 | 1 | _aBarbero, Andrea | |
700 | 1 | _aMartin, Ivan | |
773 | 0 |
_tTissue engineering. Part A _gvol. 18 _gno. 3-4 _gp. 362-72 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1089/ten.TEA.2011.0234 _zAvailable from publisher's website |
999 |
_c21142714 _d21142714 |